Latest news
25 items- SECSEC Form 15-12G filed by Avid Bioservices Inc.15-12G - Avid Bioservices, Inc. (0000704562) (Filer)
- PRAvid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor ExperienceTUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at www.avidbio.com, combines Avid's elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers. The reimagined Avid website captures the company's elevated brand throu
- INSIDERV. P., General Counsel Ziebell Mark R returned 66,799 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERDirector Thoma Jeanne returned 45,611 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERDirector Sargen Gregory returned 36,368 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERChief Operations Officer Richieri Richard A. returned 58,320 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERDirector Mackey Catherine J returned 43,379 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERChief Commercial Officer Kwietniak Matthew R. returned 50,796 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERChief Financial Officer Hart Daniel R returned 112,735 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERDirector Hancock Richard B returned 124,191 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERPresident & CEO Green Nicholas Stewart returned 159,375 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERDirector Carleone Joseph returned 130,324 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- INSIDERDirector Alegria Esther M. returned 37,746 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Avid Bioservices, Inc. (0000704562) (Issuer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECSEC Form S-8 POS filed by Avid Bioservices Inc.S-8 POS - Avid Bioservices, Inc. (0000704562) (Filer)
- SECAmendment: Avid Bioservices Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K/A - Avid Bioservices, Inc. (0000704562) (Filer)
- SECAvid Bioservices Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Avid Bioservices, Inc. (0000704562) (Filer)
CDMO FAQ
6 questionsWhat does Avid Bioservices Inc. do?
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as...Where does CDMO stock trade?
Avid Bioservices Inc. (CDMO) is listed on NASDAQ.What sector and industry is CDMO in?
Avid Bioservices Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about CDMO?
Avid Bioservices Inc. has had 8 recent analyst actions on file. The most recent action was from William Blair: Mkt Perform on 2023-09-28. Recent price targets range from $2000.00 to $3500.00.What companies are similar to CDMO?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare CDMO side-by-side with any of them on Quantisnow.How can I track CDMO on Quantisnow?
Quantisnow aggregates Avid Bioservices Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CDMO to receive live email and push alerts on every new disclosure.